PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 31 filers reported holding PHARMACYTE BIOTECH INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8 | -86.7% | 3 | -85.7% | 0.00% | – |
Q2 2023 | $60 | -33.3% | 21 | -32.3% | 0.00% | – |
Q1 2023 | $90 | -44.1% | 31 | -43.6% | 0.00% | – |
Q4 2022 | $161 | – | 55 | +77.4% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 31 | -98.8% | 0.00% | – |
Q2 2022 | $6,000 | -95.8% | 2,526 | -95.9% | 0.00% | – |
Q1 2022 | $142,000 | -16.5% | 61,869 | -9.2% | 0.00% | – |
Q4 2021 | $170,000 | +4150.0% | 68,133 | +4950.6% | 0.00% | – |
Q3 2021 | $4,000 | – | 1,349 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ayrton Capital LLC | 1,033,130 | $3,027,071 | 8.27% |
K2 PRINCIPAL FUND, L.P. | 732,105 | $2,145,068 | 0.33% |
EQUITEC PROPRIETARY MARKETS, LLC | 330,694 | $968,933 | 0.31% |
SABBY MANAGEMENT, LLC | 97,978 | $287,076 | 0.25% |
FNY Investment Advisers, LLC | 31,100 | $90 | 0.13% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 40,800 | $119,544 | 0.02% |
Aspire Private Capital, LLC | 800 | $2,344 | 0.00% |
Schonfeld Strategic Advisors LLC | 25,200 | $73,836 | 0.00% |
OSAIC HOLDINGS, INC. | 1,758 | $6,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 98 | $286 | 0.00% |